Einat Brill Almon, VP, Product Development at Protalix BioTherapeutics, Inc. (PLX), sold 50,000 shares at $8.16 ($404K) on 2010-09-07, disclosed to the SEC on 2010-09-08.
Scheduled sale ($404k) by VP, Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 27,500 | $220K | 54.5% |
| 2 | $8.16 | 22,500 | $184K | 45.5% |
| Total | $8.07 avg | 50,000 | $404K | 100% |
| Filing → |
| PLX | SELL | 2009-10-19 | $847K | — | Filing → |
| PLX | SELL | 2009-07-08 | $280K | — | Filing → |
| PLX | SELL | 2009-05-19 | $160K | — | Filing → |